Traumatic Brain Injury and Alzheimer's Disease Relationship

Pathway Diagram

Overview

This experiment investigates whether traumatic brain injury (TBI) is a causal risk factor for later AD development and the mechanisms involved. Epidemiology shows associations between moderate-severe TBI and increased AD risk, but causality and mechanisms remain unclear.

Research Question

AD Gap #18: What is the relationship between TBI and later AD?

Does TBI cause or accelerate AD pathology through specific mechanisms, and can post-TBI interventions reduce AD risk?

Hypothesis

Moderate-severe TBI triggers chronic pathophysiological changes that accelerate Aβ accumulation, tau phosphorylation, and neuroinflammation. The "one-hit" hypothesis suggests that TBI causes lasting blood-brain barrier damage and microglial priming that lowers the threshold for later AD pathogenesis.

Experimental Design

Model System

Pathway Diagram

Overview

This experiment investigates whether traumatic brain injury (TBI) is a causal risk factor for later AD development and the mechanisms involved. Epidemiology shows associations between moderate-severe TBI and increased AD risk, but causality and mechanisms remain unclear.

Research Question

AD Gap #18: What is the relationship between TBI and later AD?

Does TBI cause or accelerate AD pathology through specific mechanisms, and can post-TBI interventions reduce AD risk?

Hypothesis

Moderate-severe TBI triggers chronic pathophysiological changes that accelerate Aβ accumulation, tau phosphorylation, and neuroinflammation. The "one-hit" hypothesis suggests that TBI causes lasting blood-brain barrier damage and microglial priming that lowers the threshold for later AD pathogenesis.

Experimental Design

Model System

• Animal: Controlled cortical impact (CCI) model in APP/PS1 mice vs WT mice
• Cellular: Neuronal and microglial cultures from TBI-conditioned media exposure
• Human: Retrospective cohort of TBI patients with longitudinal biomarkers

Validation Protocol

Phase 1: Acute-Chronic TBI sequelae

Phase 2: Mechanistic Pathways

Phase 3: Human Validation

Phase 4: Intervention Testing

Expected Outcomes

Feasibility Assessment

| Factor | Rating | Notes |
|--------|-------|-------|
| Technical feasibility | 8/10 | CCI model well-established; requires longitudinal imaging |
| Cost efficiency | 5/10 | Long follow-up increases cost significantly |
| Timeline | 24 months | Mouse study (12 mo) + human validation (12 mo) |
| Cross-Disease value | 6/10 | Relevance to CTE, post-stroke dementia |

Cost Estimate

| Component | Cost (USD) |
|-----------|------------|
| Personnel (2 FTE × 24 mo) | $320,000 |
| Mouse work (150 mice) | $60,000 |
| PET imaging (mouse + human) | $180,000 |
| Human cohort (500 samples) | $100,000 |
| Biomarker assays | $80,000 |
| Total | $740,000 |

Key References

Score

Total Score: 58 (Rank 82)

| Dimension | Score |
|-----------|-------|
| Mechanistic Impact | 6 |
| Cure Proximity | 5 |
| Feasibility | 6 |
| Cost Efficiency | 5 |
| Timeline | 4 |
| Cross-Disease Value | 6 |
| Biomarker Enablement | 7 |
| Combinability | 6 |
| De-risking Value | 5 |
| Novelty | 6 |

Addressed Gap

• AD Knowledge Gap #18: What is the relationship between TBI and later AD?

See Also

• [TBI and Chronic Traumatic Encephalopathy](/experiments/tbi-cte)](/experiments)
• [Amyloid Removal Insufficient](/experiments/amyloid-removal-mechanism-insufficient)](/experiments)
• [AD Knowledge Gaps Ranked](/gaps/ad-knowledge-gaps-ranked)

Pathway Diagram

The following diagram shows the key molecular relationships involving Traumatic Brain Injury and Alzheimer's Disease Relationship discovered through SciDEX knowledge graph analysis: